2016
DOI: 10.1189/jlb.5a1015-489r
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of neutrophil function in Papillon-Lefèvre syndrome

Abstract: Papillon-Lefévre syndrome is a rare, inherited, autosomal-recessive disease, characterized by palmoplantar keratosis and severe prepubertal periodontitis, leading to premature loss of all teeth. Papillon-Lefévre syndrome is caused by a mutation in the cathepsin C gene, resulting in complete loss of activity and subsequent failure to activate immune response proteins. Periodontitis in Papillon-Lefévre syndrome is thought to arise from failure to eliminate periodontal pathogens as a result of cathepsin C deficie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
83
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(92 citation statements)
references
References 50 publications
2
83
0
1
Order By: Relevance
“…These off-targets were identified not only in human cancer cell lines, but also in liver tissue from mice treated with doses of osimertinib that match those used in the literature to block T790M-EGFR-driven tumor growth in xenograft models (Cross et al, 2014). Germline inactivating mutations in CTSC cause Papillon-Lefevre syndrome (Toomes et al, 1999), which manifests with severe periodontal disease and deregulated neutrophil function associated with increases in secreted and plasma proinflammatory cytokines (Roberts et al, 2016). That osimertinib and another covalent kinase inhibitor canertinib (Sun et al, 2016) cross-react with CTSC indicates a potentially complex effect of these oncology drugs on human immunology.…”
Section: Discussionmentioning
confidence: 99%
“…These off-targets were identified not only in human cancer cell lines, but also in liver tissue from mice treated with doses of osimertinib that match those used in the literature to block T790M-EGFR-driven tumor growth in xenograft models (Cross et al, 2014). Germline inactivating mutations in CTSC cause Papillon-Lefevre syndrome (Toomes et al, 1999), which manifests with severe periodontal disease and deregulated neutrophil function associated with increases in secreted and plasma proinflammatory cytokines (Roberts et al, 2016). That osimertinib and another covalent kinase inhibitor canertinib (Sun et al, 2016) cross-react with CTSC indicates a potentially complex effect of these oncology drugs on human immunology.…”
Section: Discussionmentioning
confidence: 99%
“…Neutrophils were isolated from the peripheral venous blood of periodontally and systemically healthy volunteers (University of Birmingham ethics reference ERN_13-0325) using discontinuous Percoll gradients (GE Healthcare, Amersham, UK) as previously described (67). The medical history was taken from each donor, and periodontal examinations were conducted to ensure periodontal and systemic health.…”
Section: Methodsmentioning
confidence: 99%
“…Thus, a dual approach is mandatory to comprehend the task of hosts' immunity in response to, against periodontitis [37]. This involves more comprehensive statistics about HNP and hBD, LL-37, and other oral antimicrobial peptides and proteins, along with their mode of action and clinical significance [38][39][40][41][42][43][44][45][46][47][48][49][50]. These peptides are peculiar in keeping the level of bacteria in control, having distinctive as well as dual roles in maintaining oral health.…”
Section: Resultsmentioning
confidence: 99%
“…Normal Lactoferrin levels Papillon-Lefe`vre syndrome [48,49] Haim-Munk syndrome [50] Palm plantar keratoderma and severe periodontitis Allelic mutations of the cathepsin C(CTSC) gene…”
Section: Alpha-defensins Deficiency ( By 70% )mentioning
confidence: 99%